The report reviews 20 years of data from US government funded surveillance systems on government drug control spending, cannabis seizures and cannabis arrests, in order to assess the impact of enforced cannabis prohibition on cannabis potency, price and availability. The report’s findings highlight the clear failure of cannabis prohibition efforts by showing that as the United States has dramatically scaled up drug law enforcement, cannabis potency has nevertheless increased, prices have dropped, and cannabis remains widely available.
Beau Kilmer, Jonathan P. Caulkins, Brittany M. Bond, Peter H. Reuter
13 အောက်တိုဘာလ 2010
The United States’ demand for illicit drugs creates markets for Mexican drug trafficking organizations (DTOs) and helps foster violence in Mexico. Some government and media sources have reported that Mexican and Colombian DTOs combined earn $18–$39 billion annually in wholesale drug proceeds and 60 percent of all Mexican DTO drug export revenue comes from marijuana. These numbers have been cited to argue that legalizing marijuana in California would reduce Mexican DTOs’ revenues, thereby reducing violence.
Registered voters in California will be the ones voting next Tuesday on whether to legalize marijuana under state law. But the ballot initiative in question – Proposition 19 – has sparked debate far beyond the state’s borders. The fate of Prop 19 is being watched especially closely in Latin America, and for good reason. Proximity to the United States – still the world’s major market for illicit drugs – has helped to stimulate robust illicit drug production and distribution networks in the region. And U.S.-backed militarized enforcement to suppress the drug industry, combined with harsh laws to punish drug users, have made the “war on drugs” more than metaphorical in many Latin American countries.
Beau Kilmer, Jonathan P. Caulkins, Rosalie Liccardo Pacula, Robert J. MacCoun, Peter H. Reuter
07 ဇူလိုင်လ 2010
To learn more about the possible outcomes of marijuana legalization in California, RAND researchers constructed a model based on a series of estimates of current consumption, current and future prices, how responsive use is to price changes, taxes levied and possibly evaded, and the aggregation of nonprice effects (such as a change in stigma).